Find a Physician

Profile http://www.stanfordhospital.org/profiles/David_Stevenson/
Email this profile
Portrait View Larger

David K. Stevenson, M.D.

Academic Appointments

  • The Harold K. Faber Professor of Pediatrics and Professor, by courtesy, of Obstetrics and Gynecology

Key Documents

Contact Information

  • Clinical Offices
    Neonatal Intensive Care Unit 725 Welch Rd 2 West Palo Alto, CA 94304
    Tel Work (650) 497-8800 Fax (650) 725-8351
  • Academic Offices
    Personal Information
    Email Tel (650) 723-4492 Tel (650) 723-5711
    Administrative Contact
    Ana Laborde Tel Work 650-723-4492

Professional Overview

Clinical Focus

  • Neonatal-Perinatal Medicine
  • Neonatology

Administrative Appointments

  • Co-Leader, Stanford Clinical and Translational Unit (CTRU) (2008 - present)
  • Leader, Spectrum Child Health (2008 - present)
  • Co-Director, Stanford Center for Clinical and Translational Education and Research (2008 - present)
  • Vice Dean, Stanford University School of Medicine (2006 - 2013)
  • Senior Associate Dean for Academic Affairs, Stanford University School of Medicine (2001 - 2013)
  • Director, Charles B. and Ann L. Johnson Center for Pregnancy and Newborn Services, Lucile Packard Children's Hospital at Stanford (1997 - present)
View All 10administrative appointments of David Stevenson

Honors and Awards

  • Member, Institute of Medicine of the National Academies, National Academy of Sciences (2012)
  • Jonas Salk Award for Leadership in Prematurity Prevention, March of Dimes Foundation (2011)
  • Maureen Andrew Mentor Award, Society for Pediatric Research (2011)
  • Albion Walter Hewlett Award, Stanford University School of Medicine (2009)
  • Alwin C. Rambar-James B.D. Mark Award for Excellence in Patient Care, Stanford University School of Medicine (2009)
  • Joseph W. St. Geme, Jr. Education Award, Western Society for Pediatric Research (2009)
View All 14honors and awards of David Stevenson

Boards, Advisory Committees, Professional Organizations

  • Chair, Maureen Andrew Mentor Award Selection Committee, Society for Pediatric Research (2013 - present)

Professional Education

Board Certification: Pediatrics, American Board of Pediatrics (1979)
Residency: University of Washington School of Medicine WA (1977)
Internship: University of Washington School of Medicine WA (1976)
Medical Education: University of Washington School of Medicine WA (1975)
Board Certification: Neonatal-Perinatal Medicine, American Board of Pediatrics (1979)
Fellowship: Stanford University Medical Center CA (1979)
View All 8

Courses

2013-14

Postdoctoral Advisees

Kazumichi Fujioka

Scientific Focus

Current Research and Scholarly Interests

Our research is focused on the study of the ontogeny and control of heme catabolism and bilirubin production in the developing neonate. A better understanding of the role of increased bilirubin production in neonatal jaundice and the prevention of hemolytic jaundice has remained an overall objective of our program. To this end, we are actively investigating a more targeted, preventive approach to the diagnosis and treatment of newborns, who are high producers of the pigment and/or unable to efficiently eliminate bilirubin, thus leading to an accumulation of the pigment in circulation and tissues, which may lead to irreversible neurologic injury. Control of bilirubin production is a logical strategy, but has unexplored consequences for the immature mammal. Thus, we are studying the pivotal role of heme oxygenase (HO), the rate-limiting enzyme in the production of bilirubin, under a variety of commonly encountered pathological conditions, such as infection and hypoxia-ischemia, as well as in anti-oxidant defense, immune response and the regulation of hematopoiesis. In support of the above interests, studies are in progress, which are designed to screen a variety of metalloporphyrins and other compounds for maximum in vitro and in vivo efficacy with minimal side effects; to determine the ontogeny of the HO enzyme system in various murine tissues, focusing on perturbations resulting from treatment with HO inhibitors; and further to develop and test new technologies for noninvasive or minimally-invasive measurements of in vivo metabolism that could be used for diagnostic and monitoring purposes.

Publications

Publication tag cloud

Publication Topics

View All 217

Stanford Medicine Resources:

Footer Links: